After ACIP Gambit, Pfizer, GSK Take RSV Vaccines To US FDA Adcomm

 
• By Sarah Karlin-Smith and Bridget Silverman

The Vaccines and Related Biological Products Advisory Committee is scheduled to consider the RSV vaccine candidates on 28 February and 1 March.

RSV virus
ACIP members preferred a higher age floor for the RSV vaccines in older adults. • Source: Shutterstock

More from Vaccines

More from Pink Sheet